Perspective on nanoparticle technology for biomedical use

Current Pharmaceutical Design

Volumn 22, Issue 17, 2016, Pages 2481-2490

  Raliya, Ramesh ^a   Chadha, Tandeep Singh ^a   Haddad, Kelsey ^a   Biswas, Pratim ^a  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Nanoparticles; Surface functionalization; Synthesis; Therapeutic application

Indexed keywords

NANOPARTICLE;

AEROSOL; BIOMEDICAL ENGINEERING; BIOSENSOR; CRYSTAL STRUCTURE; DRUG DELIVERY SYSTEM; HUMAN; INTERNALIZATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; SYNTHESIS; ANIMAL; CHEMISTRY; MEDICAL RESEARCH; NANOTECHNOLOGY; PARTICLE SIZE;

ANIMALS; BIOMEDICAL RESEARCH; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; SURFACE PROPERTIES;

EID: 84974678612     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666160307151409     Document Type: Review

References (150)

1. Wong PT, Choi SK. Mechanisms of drug release in nanotherapeutic delivery systems. Chem Rev 2015; 115: 3388-432.
2. Aznar E, Climent E, Mondragon L, Sancenón F, Martínez-Máñez R. Functionalized mesoporous materials with gate-like scaffoldings for controlled delivery. In: Pradas MM, Vicent MJ, Eds. Polymers in Regenerative Medicine: Biomedical Application from Nano-to Macro-Structures. USA: John Wiley & Sons. Inc. 2015; pp. 337-66.
3. Che E, Gao Y, Wan L, et al. Paclitaxel/gelatin coated magnetic mesoporous silica nanoparticles: Preparation and antitumor efficacy in vivo. Microporous Mesoporous Mater 2015; 204: 226-34.
4. Hughes GA. Nanostructure-mediated drug delivery. Nanomed Nanotechnol Biol Med 2005; 1: 22-30.
5. Chung C, Kim YK, Shin D, Ryoo S-R, Hong BH, Min DH. Biomedical applications of graphene and graphene oxide. Acc Chem Res 2013; 46: 2211-24.
6. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev 2012; 41: 2256-82.
7. Chaudhary A. Ayurvedic Bhasma: nanomedicine of ancient India-its global contemporary perspective. J Biomed Nanotechnol 2011; 7: 68-9.
8. Pal D, Sahu CK, Haldar A. Bhasma: the ancient Indian nanomedicine. J Adv Pharm Technol Res 2014; 5: 4-12.
9. De Villiers MM, Aramwit P, Kwon GS. Nanotechnology in drug delivery. USA: Springer Science Business Media 2008; p. 662.
10. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009; 3: 16-20.
11. Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003; 8: 1112-20.
12. Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005; 172: 1487-90.
13. Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Exp Opin Drug Deliv 2015: 1-15.
14. Smith JD, Morton LD, Ulery BD. Nanoparticles as synthetic vaccines. Curr Opin Biotechnol 2015; 34: 217-24.
15. Dames P, Gleich B, Flemmer A, et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol 2007; 2: 495-9.
16. Beck-Broichsitter M, Merkel OM, Kissel T. Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J Control Release 2012; 161: 214-24.
17. Chattopadhyay S. Aerosol generation using nanometer liposome suspensions for pulmonary drug delivery applications. J Liposom Res 2013; 23: 255-67.
18. Labhasetwar V. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery. Curr Opin Biotechnol 2005; 16: 674-80.
19. Jung S, Patzelt A, Otberg N, Thiede G, Sterry W, Lademann J. Strategy of topical vaccination with nanoparticles. J Biomed Optics 2009; 14: 021001-7.
20. Chadha TS, Chattopadhyay S, Venkataraman C, Biswas P. Study of the charge distribution on liposome particles aerosolized by airjet atomization. J Aerosol Med Pulm Drug Deliv 2012; 25: 355-64.
21. Csaba N, Garcia-Fuentes M, Alonso MJ. Nanoparticles for nasal vaccination. Adv Drug Deliv Rev 2009; 61: 140-57.
22. O’Riordan TG. Aerosol delivery devices and obstructive airway disease. Expert Rev Med Devices 2005; 2: 197-203.
23. Dinwiddie R. Anti-inflammatory therapy in cystic fibrosis. J Cystic Fibrosis 2005; 4: 45-8.
24. Hagerman JK, Hancock KE, Klepser ME. Aerosolised antibiotics: a critical appraisal of their use. Expert Opin Drug Deliv 2006; 3: 71-86.
25. Rao R, Markovic S, Anderson P. Aerosol therapy for malignancy involving the lungs. Curr Cancer Drug Targets 2003; 3: 239-50.
26. Bennett WD, Brown JS, Zeman KL, Hu SC, Scheuch G, Sommerer K. Targeting delivery of aerosols to different lung regions. J Aerosol Med 2002; 15: 179-88.
27. Card JW, Zeldin DC, Bonner JC, Nestmann ER. Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol-Lung Cell Mol Physiol 2008; 295: L400-11.
28. Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet 2011; 377: 1032-45.
29. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 2008; 105: 14265-70.
30. Tenzer S, Docter D, Kuharev J, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 2013; 8: 772-81.
31. Monopoli MP, Walczyk D, Campbell A, et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011; 133: 2525-34.
32. Nune SK, Gunda P, Thallapally PK, Lin Y-Y, Laird Forrest M, Berkland CJ. Nanoparticles for biomedical imaging. Expert Opin Drug Deliv 2009; 6: 1175-94.
33. Choi HS, Frangioni JV. Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol Imaging 2010; 9: 291-310.
34. Erathodiyil N, Ying JY. Functionalization of inorganic nanoparticles for bioimaging applications. Acc Chem Res 2011; 44: 925-35.
35. Nam J, Won N, Bang J, et al. Surface engineering of inorganic nanoparticles for imaging and therapy. Adv Drug Deliv Rev 2013; 65: 622-48.
36. Jin R, Lin B, Li D, Ai H. Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 2014; 18: 18-27.
37. Sun C, Lee JSH, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008; 60: 1252-65.
38. Choi JH, Nguyen FT, Barone PW, et al. Multimodal biomedical imaging with asymmetric single-walled carbon nanotube/iron oxide nanoparticle complexes. Nano Lett 2007; 7: 861-7.
39. Sharifi S, Seyednejad H, Laurent S, Atyabi F, Saei AA, Mahmoudi M. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging. Contrast Media Mol Imaging 2015; 10(5): 329-55.
40. Jain PK, Huang X, El-Sayed IH, El-Sayed MA. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 2008; 41: 1578-86.
41. Bao C, Conde J, Polo E, et al. A promising road with challenges: where are gold nanoparticles in translational research? Nanomedicine 2014; 9: 2353-70.
42. Hu M, Chen J, Li ZY, et al. Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem Soc Rev 2006; 35: 1084-94.
43. Cobley CM, Chen J, Cho EC, Wang LV, Xia Y. Gold nanostructures: a class of multifunctional materials for biomedical applications. Chem Soc Rev 2011; 40: 44-56.
44. Kim S, Lim C-K, Na J, et al. Conjugated polymer nanoparticles for biomedical in vivo imaging. Chem Commun 2010; 46: 1617-9.
45. Zhu S, Zhang J, Tang S, et al. surface chemistry routes to modulate the photoluminescence of graphene quantum dots: from fluorescence mechanism to up-conversion bioimaging applications. Adv Funct Mater 2012; 22: 4732-40.
46. Selvan S, Patra PK, Ang CY, Ying JY. Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angew Chem 2007; 119: 2500-4.
47. Law WC, Yong KT, Roy I, et al. Aqueous-phase synthesis of highly luminescent CdTe/ZnTe core/shell quantum dots optimized for targeted bioimaging. Small 2009; 5: 1302-10.
48. Kong RM, Zhang XB, Chen Z, Tan W. Aptamer-assembled nanomaterials for biosensing and biomedical applications. Small 2011; 7: 2428-36.
49. Hu R, Zhang X-B, Kong R-M, Zhao X-H, Jiang J, Tan W. Nucleic acid-functionalized nanomaterials for bioimaging applications. J Mater Chem 2011; 21: 16323-34.
50. Meadows D. Recent developments with biosensing technology and applications in the pharmaceutical industry. Adv Drug Deliv Rev 1996; 21: 179-89.
51. Taguchi N. A Metal Oxide Gas Sensor. Jpn Patent 1962: 45-38200.
52. Seiyama T, Kato A, Fujiishi K, Nagatani M. A New detector for gaseous components using semiconductive thin films. Anal Chem 1962; 34: 1502-3.
53. Korotcenkov G. Metal oxides for solid-state gas sensors: What determines our choice? Mater Sci Eng 2007; 139: 1-23.
54. 2 thin films: High gas-sensing properties by control of morphology. Sens Actuat B Chem 2010; 150: 609-615.
55. 3 nanoneedles and their application in high sensitivity gas sensor devices. Chem Commun 2011; 47: 565-7.
56. Vallejos S, Umek P, Stoycheva T, et al. Single-step deposition of au-and pt-nanoparticle-functionalized tungsten oxide nanoneedles synthesized via aerosol-assisted cvd, and used for fabrication of selective gas microsensor arrays. Adv Funct Mater 2013; 23: 1313-22.
57. 3 for sensing of acetone in the human breath. Chem Mater 2010; 22: 3152-7.
58. 3 sensors for noninvasive diabetes diagnosis by breath analysis. Sensors 2010 IEEE, 2010; pp. 1491-5.
59. Righettoni M, Tricoli A. Toward portable breath acetone analysis for diabetes detection. J Breath Res 2011; 5: 037109.
60. 3 gas sensors. Anal Chim Acta 2012; 738: 69-75.
61. 2 hollow spheres for real-time diagnosis of halitosis. Sens Actuat B Chem 2014; 194: 371-6.
62. Cui S, Guo X, Ren R, Zhou G, Chen J. Decoration of vertical graphene with aerosol nanoparticles for gas sensing. J Phys D: Appl Phys 2015; 48: 314008.
63. Si P, Huang Y, Wang T, Ma J. Nanomaterials for electrochemical non-enzymatic glucose biosensors. RSC Adv 2013; 3: 3487-502.
64. Kim SK, Chang H, Choi J-W, Huang J, Jang HD. Aerosol processing of graphene and its application to oil absorbent and glucose biosensor. KONA Powder Particle J 2014; 31: 111-25.
65. Jang HD, Kim SK, Chang H, et al. Synthesis of 3D silvergraphene-titanium dioxide composite via aerosol spray pyrolysis for sensitive glucose biosensor. Aerosol Sci Technol 2015; 49: 538-46.
66. Hinds WC. Aerosol technology: properties, behavior, and measurement of airborne particles. New York: Wiley-Interscience 1982; p. 442.
67. AAQRL. Aerosol and Air Quality Reesearch laboratory. http://aerosols.eece.wustl.edu/, Accessed on July 30 2015.
68. Hickey AJ. Pharmaceutical Inhalation Aerosol Technology. USA: CRC Press 2003 p. 288.
69. Tricoli A, Graf M, Mayer F, Kuühne S, Hierlemann A, Pratsinis SE. Micropatterning layers by flame aerosol deposition-annealing. Adv Mater 2008; 20: 3005-10.
70. An W-J, Thimsen E, Biswas P. Aerosol-chemical vapor deposition method for synthesis of nanostructured metal oxide thin films with controlled morphology. J Phys Chem Lett 2009; 1: 249-53.
71. Wang Z-M, Yang G, Biswas P, Bresser W, Boolchand P. Processing of iron-doped titania powders in flame aerosol reactors. Powder Technol 2001; 114: 197-204.
72. Kruis FE, Fissan H, Peled A. Synthesis of nanoparticles in the gas phase for electronic, optical and magnetic applications-a review. J Aerosol Sci 1998; 29: 511-35.
73. Fang J, Leavey A, Biswas P. Controlled studies on aerosol formation during biomass pyrolysis in a flat flame reactor. Fuel 2014; 116: 350-7.
74. Hahn H. Gas phase synthesis of nanocrystalline materials. Nanostruct Mater 1997; 9: 3-12.
75. 3. Chem Mater 2008; 20: 4906-14.
76. Li C, Ma C, Wang F, et al. Preparation and biomedical applications of core-shell silica/magnetic nanoparticle composites. J Nanosci Nanotechnol 2012; 12: 2964-72.
77. Deng Y-H, Wang C-C, Hu J-H, Yang W-L, Fu S-K. Investigation of formation of silica-coated magnetite nanoparticles via sol-gel approach. Colloids Surfaces A: Physicochem Eng Aspects 2005; 262: 87-93.
78. Jiang J, Chen D-R, Biswas P. Synthesis of nanoparticles in a flame aerosol reactor with independent and strict control of their size, crystal phase and morphology. Nanotechnology 2007; 18: 285603.
79. Tiwari V, Jiang J, Sethi V, Biswas P. One-step synthesis of noble metal-titanium dioxide nanocomposites in a flame aerosol reactor. Appl Catalysis A: General 2008; 345: 241-6.
80. Wang W-N, Jiang Y, Biswas P. Evaporation-induced crumpling of graphene oxide nanosheets in aerosolized droplets: confinement force relationship. J Phys Chem Lett 2012; 3: 3228-3.
81. 2 nanostructures for near-infrared water photolysis. J Nanoparticle Res 2014; 16: 1-9.
82. Tricoli A, Righettoni M, Teleki A. Semiconductor gas sensors: dry synthesis and application. Angew Chem Int Ed 2010; 49: 7632-59.
83. Basak S, Chen D-R, Biswas P. Electrospray of ionic precursor solutions to synthesize iron oxide nanoparticles: modified scaling law. Chem Eng Sci 2007; 62: 1263-8.
84. Chattopadhyay S, Modesto-Lopez LB, Venkataraman C, Biswas P. Size distribution and morphology of liposome aerosols generated by two methodologies. Aerosol Sci Technol 2010; 44: 972-82.
85. Sun Y, Xia Y. Shape-controlled synthesis of gold and silver nanoparticles. Science 2002; 298: 2176-9.
86. Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman R. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. J Chem Soc Chem Commun 1994; 801-2.
87. Gu H, Zheng R, Zhang X, Xu B. Facile one-pot synthesis of bifunctional heterodimers of nanoparticles: a conjugate of quantum dot and magnetic nanoparticles. J Am Chem Soc 2004; 126: 5664-5.
88. Du H, Hamilton PD, Reilly MA, d’Avignon A, Biswas P, Ravi N. A facile synthesis of highly water-soluble, core-shell organo-silica nanoparticles with controllable size via sol-gel process. J Colloid Interface Sci 2009; 340: 202-8.
89. Yi DK, Selvan ST, Lee SS, Papaefthymiou GC, Kundaliya D, Ying JY. Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. J Am Chem Soc 2005; 127: 4990-1.
90. Selvan ST, Bullen C, Ashokkumar M, Mulvaney P. Synthesis of Tunable, highly luminescent QD-glasses through sol-gel processing. Adv Mater 2001; 13: 985-8.
91. Daniel M-C, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 2004; 104: 293-346.
92. Eliezer S, Eliaz N, Grossman E, et al. Synthesis of nanoparticles with femtosecond laser pulses. Phys Rev B 2004; 69: 144119.
93. Deguchi S, Mukai S-A, Tsudome M, Horikoshi K. Facile Generation of fullerene nanoparticles by hand-grinding. Adv Mater 2006; 18: 729-32.
94. Lu J, Ng KM, Yang S. Efficient, one-step mechanochemical process for the synthesis of ZnO nanoparticles. Indus Eng Chem Res 2008; 47: 1095-101.
95. Raliya R, Rathore I, Tarafdar JC. Development of microbial nanofactory for zinc, magnesium, and titanium nanoparticles production using soil fungi. J Bionanosci 2013; 7: 590-6.
96. Raliya R, Biswas P. Environmentally benign bio-inspired synthesis of Au nanoparticles, their self-assembly and agglomeration. RSC Adv 2015; 5: 42081-7.
97. Raliya R, Tarafdar J. Biosynthesis of gold nanoparticles using rhizoctonia bataticola TFR-6. Adv Sci, Eng Med 2013; 5: 1073-6.
98. Raliya R, Tarafdar J. Novel approach for silver nanoparticle synthesis using Aspergillus terreus CZR-1: mechanism perspective. J Bionanosci 2012; 6: 12-6.
99. Raliya JCTR. Rapid, low-cost, and ecofriendly approach for iron nanoparticle synthesis using Aspergillus oryzae TFR9. J Nanoparticles 2013; 2013: 141274.
100. Tarafdar J, Raliya R, Rathore I. Microbial synthesis of phosphorous nanoparticle from tri-calcium phosphate using Aspergillus tubingensis TFR-5. J Bionanosci 2012; 6: 84-9.
101. 2 nanoparticle using Aspergillus tubingensis. Adv Sci, Eng Med 2013; 5: 943-9.
102. Raliya R, Tarafdar JC, Choudhary K,et al. Synthesis of MgO Nanoparticles Using Aspergillus Tubingensis TFR-3. J Bionanosci 2014; 8: 34-8.
103. Tang L, Cheng J. Nonporous silica nanoparticles for nanomedicine application. Nano Today 2013; 8: 290-312.
104. Callejas-Fernández J, Estelrich J, Quesada-Pérez M, Forcada J. Soft Nanoparticles for Biomedical Applications. UK: Royal Society of Chemistry 2014.
105. Slowing II, Vivero-Escoto JL, Wu C-W, Lin VS-Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008; 60: 1278-88.
106. Tzur-Balter A, Shatsberg Z, Beckerman M, Segal E, Artzi N. Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues. Nat Commun 2015; 6: 6208.
107. Chen J, Wiley B, Li ZY, et al. Gold nanocages: engineering their structure for biomedical applications. Adv Mater 2005; 17: 2255-61.
108. Zhang S. Fabrication of novel biomaterials through molecular selfassembly. Nat Biotechnol 2003; 21: 1171-8.
109. Jiang J, Oberdörster G, Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanoparticle Res 2009; 11: 77-89.
110. Jiang J, Oberdörster G, Elder A, Gelein R, Mercer P, Biswas P. Does nanoparticle activity depend upon size and crystal phase? Nanotoxicology 2008; 2: 33-42.
111. Suttiponparnit K, Jiang J, Sahu M, Suvachittanont S, Charinpanitkul T, Biswas P. Role of surface area, primary particle size, and crystal phase on titanium dioxide nanoparticle dispersion properties. Nanoscale Res Lett 2011; 6: 27.
112. Auffan M, Rose J, Bottero J-Y, Lowry GV, Jolivet J-P, Wiesner MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol 2009; 4: 634-41.
113. 2 nanoparticles in anatase and rutile crystal phase. Biol Trace Element Res 2011; 141: 3-15.
114. Hinton TM, Grusche F, Acharya D, et al. Bicontinuous cubic phase nanoparticle lipid chemistry affects toxicity in cultured cells. Toxicol Res 2014; 3: 11-22.
115. Kreyling WG, Biswas P, Messing ME, et al. Generation and characterization of stable, highly concentrated titanium dioxide nanoparticle aerosols for rodent inhalation studies. J Nanoparticle Res 2011; 13: 511-24.
116. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995-4021.
117. Mout R, Moyano DF, Rana S, Rotello VM. Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev 2012; 41: 2539-44.
118. Villanueva A, Canete M, Roca AG, et al. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology 2009; 20: 115103.
119. Keller AA, Wang H, Zhou D, et al. Stability and aggregation of metal oxide nanoparticles in natural aqueous matrices. Environ Sci Technol 2010; 44: 1962-7.
120. Zhou J, Ralston J, Sedev R, Beattie DA. Functionalized gold nanoparticles: synthesis, structure and colloid stability. J Colloid Interface Sci 2009; 331: 251-62.
121. Stebounova LV, Guio E, Grassian VH. Silver nanoparticles in simulated biological media: a study of aggregation, sedimentation, and dissolution. J Nanoparticle Res 2011; 13: 233-44.
122. Moghadam BY, Hou W-C, Corredor C, Westerhoff P, Posner JD. Role of nanoparticle surface functionality in the disruption of model cell membranes. Langmuir 2012; 28: 16318-26.
123. Kettler K, Veltman K, van de Meent D, van Wezel A, Hendriks AJ. Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ Toxicol Chem 2014; 33: 481-92.
124. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-110.
125. Sarkar K, Banerjee SL, Kundu PP, Madras G, Chatterjee K. Biofunctionalized surface-modified silver nanoparticles for gene delivery. J Mater Chem 2015; 3: 5266-76.
126. Numata Y, Mazzarino L, Borsali R. A slow-release system of bacterial cellulose gel and nanoparticles for hydrophobic active ingredients. Int J Pharm 2015; 486: 217-25.
127. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 2012; 64: 246-55.
128. Pelaz B, del Pino P, Maffre P, et al. Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake. ACS Nano 2015; 9: 6996-7008.
129. Gupta AK, Curtis AS. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J Mater Sci: Mater Med 2004; 15: 493-6.
130. Gao Y, Lim J, Teoh S-H, Xu C. Emerging translational research on magnetic nanoparticles for regenerative medicine. Chem Soc Rev 2015; 44(17): 6306-29.
131. Gref R, Domb A, Quellec P, et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 2012; 64: 316-26.
132. Labala S, Mandapalli PK, Kurumaddali A, Venuganti VVK. Layerby-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma. Mol Pharm 2015; 12: 878-88.
133. Feng J-J, Zhao G, Xu J-J, Chen H-Y. Direct electrochemistry and electrocatalysis of heme proteins immobilized on gold nanoparticles stabilized by chitosan. Analytical Biochem 2005; 342: 280-6.
134. Sarkar S, Guibal E, Quignard F, SenGupta A. Polymer-supported metals and metal oxide nanoparticles: synthesis, characterization, and applications. J Nanoparticle Res 2012; 14: 1-24.
135. Unsoy G, Yalcin S, Khodadust R, Gunduz G, Gunduz U. Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications. J Nanoparticle Res 2012; 14: 1-13.
136. Ma HL, Xu YF, Qi XR, Maitani Y, Nagai T. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int J Pharm 2008; 354: 217-26.
137. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 2008; 60: 1650-62.
138. Rescignano N, Fortunati E, Armentano I, et al. Use of alginate, chitosan and cellulose nanocrystals as emulsion stabilizers in the synthesis of biodegradable polymeric nanoparticles. J Colloid Interface Sci 2015; 445: 31-9.
139. Castelló J, Gallardo M, Busquets MA, Estelrich J. Chitosan (or alginate)-coated iron oxide nanoparticles: A comparative study. Colloids Surfaces A: Physicochem Eng Aspects 2015; 468: 151-8.
140. Mallick N, Asfer M, Anwar M, et al. Rhodamine-loaded, crosslinked, carboxymethyl cellulose sodium-coated super-paramagnetic iron oxide nanoparticles: Development and in vitro localization study for magnetic drug-targeting applications. Colloids Surfaces A: Physicochem Eng Aspects 2015; 481: 51-62.
141. Foox M, Zilberman M. Drug delivery from gelatin-based systems. Expert Opin Drug Deliv 2015; 12: 1547-63.
142. Ling D, Lee N, Hyeon T. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications. Acc Chem Res 2015; 48: 1276-85.
143. Chen Q, Wang H, Liu H, et al. Multifunctional dendrimerentrapped gold nanoparticles modified with RGD peptide for targeted computed tomography/magnetic resonance dual-modal imaging of tumors. Anal Chem 2015; 87: 3949-56.
144. Sahoo Y, Pizem H, Fried T, et al. Alkyl phosphonate/phosphate coating on magnetite nanoparticles: a comparison with fatty acids. Langmuir 2001; 17: 7907-11.
145. 4 nanoparticles for adsorption and determination of benzo (a) pyrene in environmental water samples. Chem Eng J 2015; 271: 232-9.
146. Easo SL, Mohanan P. In vitro hematological and in vivo immunotoxicity assessment of dextran stabilized iron oxide nanoparticles. Colloids Surfaces B: Biointerfaces 2015; 134: 122-30.
147. Hauser AK, Mathias R, Anderson KW, Hilt JZ. The effects of synthesis method on the physical and chemical properties of dextran coated iron oxide nanoparticles. Mater Chem Phys 2015; 160: 177-86.
148. Liu J-N, Bu W-B, Shi J-L. Silica coated upconversion nanoparticles: A versatile platform for the development of efficient theranostics. Acc Chem Res 2015; 48: 1797-805.
149. Mirkin CA, Rosi NL, Thaxton CS, Giljohann DA. Nucleic acid functionalized nanoparticles for therapeutic applications. U.S. Patent 8,999,947, issued April 7 2015.
150. Karakoti AS, Shukla R, Shanker R, Singh S. Surface functionalization of quantum dots for biological applications. Adv Colloid Interface Sci 2015; 215: 28-45.